Equitable Community Access to Pharmacist Services Act
Current understanding
A Senate bill (introduced, referred to committee) that would permanently authorize Medicare Part B payment for pharmacist-furnished testing and treatment services for COVID-19, influenza, RSV, strep throat, and other specified conditions during a declared public health emergency, contingent on state scope-of-practice law. The bill would establish pharmacists as a recognized Medicare-billable provider for a narrow set of infectious disease services, extending pandemic-era PREP Act flexibilities into permanent Medicare law.
Evidence log
- 2025-07-24 — Equitable Community Access to Pharmacist Services Act: cross-connection with prep-act: The bill would make permanent under Medicare the kind of pharmacist testing/treatment authorities that were expanded on an emergency basis under PREP Act declarations. (novelty: 2)